Viewing Study NCT05589818


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2026-03-01 @ 6:10 AM
Study NCT ID: NCT05589818
Status: RECRUITING
Last Update Posted: 2025-06-25
First Post: 2022-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab for Advanced NSCLC and PS 2-3
Sponsor: Icahn School of Medicine at Mount Sinai
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module